DK1453916T3 - Kombination indeholdende en poloxamer og chondroitinsvovlsyre og/eller et glycoprotein og anvendelse deraf - Google Patents

Kombination indeholdende en poloxamer og chondroitinsvovlsyre og/eller et glycoprotein og anvendelse deraf

Info

Publication number
DK1453916T3
DK1453916T3 DK02804612.6T DK02804612T DK1453916T3 DK 1453916 T3 DK1453916 T3 DK 1453916T3 DK 02804612 T DK02804612 T DK 02804612T DK 1453916 T3 DK1453916 T3 DK 1453916T3
Authority
DK
Denmark
Prior art keywords
poloxamer
glycoprotein
sulfuric acid
combination containing
chondroitin sulfuric
Prior art date
Application number
DK02804612.6T
Other languages
English (en)
Inventor
Alain Mavon
Henri Cousse
Pascal Bordat
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8870369&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1453916(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Application granted granted Critical
Publication of DK1453916T3 publication Critical patent/DK1453916T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/594—Mixtures of polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Polymers & Plastics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK02804612.6T 2001-12-12 2002-12-12 Kombination indeholdende en poloxamer og chondroitinsvovlsyre og/eller et glycoprotein og anvendelse deraf DK1453916T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116033A FR2833268B1 (fr) 2001-12-12 2001-12-12 Nouvelle association contenant un poloxamer et de l'acide chondroitine sulfurique et/ou une glycoproteine et son utilisation
PCT/FR2002/004313 WO2003050190A2 (fr) 2001-12-12 2002-12-12 Nouvelle association contenant un poloxamer et de l'acide chondroitine sulfurique et/ou une glycoproteine et son utilisation

Publications (1)

Publication Number Publication Date
DK1453916T3 true DK1453916T3 (da) 2011-08-15

Family

ID=8870369

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02804612.6T DK1453916T3 (da) 2001-12-12 2002-12-12 Kombination indeholdende en poloxamer og chondroitinsvovlsyre og/eller et glycoprotein og anvendelse deraf

Country Status (10)

Country Link
EP (1) EP1453916B1 (da)
JP (1) JP4786869B2 (da)
AT (1) ATE509066T1 (da)
CA (1) CA2470102C (da)
DK (1) DK1453916T3 (da)
ES (1) ES2365327T3 (da)
FR (1) FR2833268B1 (da)
PT (1) PT1453916E (da)
SI (1) SI1453916T1 (da)
WO (1) WO2003050190A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4712296B2 (ja) * 2003-12-11 2011-06-29 株式会社 資生堂 ポスト処理用皮膚外用剤およびそれを用いた化粧方法
EP2116139A1 (en) * 2008-05-08 2009-11-11 Nestec S.A. Sialic acid to support brain health in the elderly
CA2740509A1 (en) 2008-10-30 2010-05-06 Medlite A/S Formulation for treatment of vaginal dryness
CA2837240A1 (en) * 2011-05-27 2012-12-06 Ratiopharm Gmbh Ophthalmic preparation comprising a pgf2.alpha. analogue
ES2884813T3 (es) 2013-03-13 2021-12-13 Buzzard Pharmaceuticals AB Formulaciones de citoquina quimérica para administración ocular
US9463201B2 (en) 2014-10-19 2016-10-11 M.G. Therapeutics Ltd Compositions and methods for the treatment of meibomian gland dysfunction
CN108472312A (zh) 2015-09-28 2018-08-31 阿祖拉眼科有限公司 用于增加睑板腺脂质分泌物的含硫醇及二硫化物的药剂
US11040062B2 (en) 2016-04-14 2021-06-22 Azura Ophthalmics Ltd. Selenium disulfide compositions for use in treating meibomian gland dysfunction
CA3166357A1 (en) 2020-01-10 2021-07-15 Azura Ophthalmics Ltd. Instructions for composition and sensitivity

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61103836A (ja) * 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
JPH0283318A (ja) * 1988-09-20 1990-03-23 Zeria Pharmaceut Co Ltd 安定な点眼剤
JPH0776175B2 (ja) * 1990-04-26 1995-08-16 サイトアーレクス・コーポレーシヨン 損傷されたかまたは病気になった組織の局所的処置用の組成物および方法
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US5945409A (en) * 1995-03-10 1999-08-31 Wilson T. Crandall Topical moisturizing composition and method
AU1558597A (en) * 1996-02-07 1997-08-28 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition with regulated viscosity
EP0920338A2 (en) * 1996-08-12 1999-06-09 MedLogic Global Corporation Composition for pharmaceutical applications
US5906997A (en) * 1997-06-17 1999-05-25 Fzio Med, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
JPH11189548A (ja) * 1997-12-25 1999-07-13 Toshio Sato 無晶性医薬組成物及びその製造方法
ES2255987T3 (es) * 1999-03-01 2006-07-16 Milcin Therapeutics Llc Preparaciones oftalmicas conteniendo mucina.
US6814959B1 (en) * 1999-07-13 2004-11-09 Pharmasol Gmbh UV radiation reflecting or absorbing agents, protecting against harmful UV radiation and reinforcing the natural skin barrier
JP2003513951A (ja) * 1999-11-09 2003-04-15 アルコン，インコーポレイテッド ヒドロキシエイコサテトラエン酸誘導体を含有する組成物およびドライアイ障害の処置における使用方法
JP2001318350A (ja) * 2000-05-11 2001-11-16 Lion Corp コンタクトレンズ用溶液

Also Published As

Publication number Publication date
EP1453916B1 (fr) 2011-05-11
FR2833268B1 (fr) 2005-07-08
CA2470102A1 (fr) 2003-06-19
WO2003050190A3 (fr) 2003-12-11
FR2833268A1 (fr) 2003-06-13
ATE509066T1 (de) 2011-05-15
JP2005527649A (ja) 2005-09-15
JP4786869B2 (ja) 2011-10-05
CA2470102C (fr) 2011-09-20
SI1453916T1 (sl) 2011-08-31
PT1453916E (pt) 2011-07-25
EP1453916A2 (fr) 2004-09-08
WO2003050190A2 (fr) 2003-06-19
ES2365327T3 (es) 2011-09-29

Similar Documents

Publication Publication Date Title
BR0205597A (pt) Composição para a tintura de oxidação das fibras queratìnicas, composição pronta para o uso para a tintura de oxidação das fibras queratìnicas, processos de tintura das fibras queratìnicas e dispositivos com vários compartimentos ou 'kit' para a tintura das fibras queratìnicas
BR0115665A (pt) Composição de tratamento das queratìnicas, uso de uma composição, processo de tratamento das matérias queratìnicas e uso de pelo menos um poliuretano associativo catiÈnico
BR0100135A (pt) Composição e processo de lavagem de matériais queratìnicas e utilização de pelo menos um éster de ácido c8-c30 de sorbitano
BR9910251A (pt) Estimulação hematopoiética
BR0115653A (pt) Composição pronta para o uso para a descoloração ou a deformação para fibras queratìnicas, composição anidra para a descoloração ou a deformação das fibras queratìnicas, composição para a deformação permanente, processo de descoloração ou de deformação permanente das fibras queratìnicas e dispositivo com dois compartimentos ou 'kit' para a descoloração ou a deformação permanente das fibras queratìnicas humanas
BR0204980B1 (pt) Composições cosméticas que contêm pelo menos um silicone aminado e um agente espessante, uso de uma composição, uso de pelo menos um silicone aminado e processo de tratamento das matérias queratínicas
BR0204979A (pt) Composição cosmética destinada ao tratamento das fibras queratìnicas humanas que compreende um silicone aminado particular, processo de tintura de oxidação, de tratamento e descoloração das fibras queratìnicas humanas, e uso de pelo menos um silicone aminado
BR0005140A (pt) Composição cosmética, sua utilização e processo de tratamento das matérias queratìnicas
NO20030411L (no) Farmasöytiske sammensetninger for behandlingen av smertefulle, inflammatoriske og ulceröse tilstander av fuktige epiteloverflater slik sommukositt, stomatitt og Behcets syndrom
BR0211390A (pt) Tratamento de infecções da unha com no
BR0112461A (pt) Composições que contém componentes terapeuticamente ativos tendo uma solubilidade aumentada
DE60126509D1 (de) Oxidative zusammensetzung zur behandlung keratinischer materialien auf der basis von amphiphilen polymeren, die mindestens ein ethylenisch ungesättigtes sulfonsäuregruppen tragendes monomer und einen hydrphoben teil enthalten
BR0113087A (pt) Novas composições de minoxidil
AR035697A1 (es) Polimero cationico dispersable en agua, un metodo para hacer el mismo y articulos usando los mismos
BR0204935A (pt) Composição de tintura para fibras queratìnicas humanas que compreende um colorante direto ou de oxidação e um silicone aminado particular, processo e dispositivos com 2 e 3 compartimentos ou 'kit' para a tintura das fibras queratìnicas humanas
BR0203758A (pt) Composição cosmética que contêm um copolìmero reticulado de ácido metacrìlico, um polìmero catiÈnico e silicone, processo de tratamento das matérias queratìnicas, uso de um copolìmero reticulado e uso de uma composição
BR0204923A (pt) Processo e kit de deformação permanente das fibras queratìnicas que compreende silicone aminado e uso de uma composição cosmética
DK1453916T3 (da) Kombination indeholdende en poloxamer og chondroitinsvovlsyre og/eller et glycoprotein og anvendelse deraf
BR0204934A (pt) Composição de tintura para fibras queratìnicas humanas que compreende um silicone aminado particular, processo e dispositivo com 2 ou 3 compartimentos ou 'kit' para a tintura das fibras queratìnicas humanas
WO2002102351A3 (en) Compositions comprising a cationic homopolymer and their use for stabilization of an oxidizing solution
BR0110758A (pt) Agente cosmético para cabelos, e, uso de agentes
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
MXPA02010957A (es) Composicion reductora para el tratamiento de las fibras queratinicas que comprende una silicona aminada particular.
BR0305479A (pt) Composição para a tintura de oxidação das fibras queratìnicas e composição pronta para o uso
ES2042468T3 (es) Producto para la fijacion del cabello.